147 related articles for article (PubMed ID: 9066027)
1. A quantitative study of the efficacy of a deletion mutant bovine herpesvirus-1 differential vaccine in reducing the establishment of latency by wildtype virus.
Galeota JA; Flores EF; Kit S; Kit M; Osorio FA
Vaccine; 1997 Feb; 15(2):123-8. PubMed ID: 9066027
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves.
Inman M; Lovato L; Doster A; Jones C
J Virol; 2002 Jul; 76(13):6771-9. PubMed ID: 12050390
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
4. Infection of cattle with a bovine herpesvirus 1 strain that contains a mutation in the latency-related gene leads to increased apoptosis in trigeminal ganglia during the transition from acute infection to latency.
Lovato L; Inman M; Henderson G; Doster A; Jones C
J Virol; 2003 Apr; 77(8):4848-57. PubMed ID: 12663791
[TBL] [Abstract][Full Text] [Related]
5. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle.
Zhu X; Letchworth GJ
Vaccine; 1996 Jan; 14(1):61-9. PubMed ID: 8821651
[TBL] [Abstract][Full Text] [Related]
7. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
8. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines.
Jones C; Chowdhury S
Anim Health Res Rev; 2007 Dec; 8(2):187-205. PubMed ID: 18218160
[TBL] [Abstract][Full Text] [Related]
9. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
Schynts F; Lemaire M; Ros C; Belak S; Thiry E
Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
[TBL] [Abstract][Full Text] [Related]
10. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
[TBL] [Abstract][Full Text] [Related]
11. Latency-related gene encoded by bovine herpesvirus 1 promotes virus growth and reactivation from latency in tonsils of infected calves.
Perez S; Inman M; Doster A; Jones C
J Clin Microbiol; 2005 Jan; 43(1):393-401. PubMed ID: 15635000
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals.
Flores EF; Osorio FA; Zanella EL; Kit S; Kit M
J Vet Diagn Invest; 1993 Oct; 5(4):534-40. PubMed ID: 8286451
[TBL] [Abstract][Full Text] [Related]
13. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency.
Jones C; Geiser V; Henderson G; Jiang Y; Meyer F; Perez S; Zhang Y
Vet Microbiol; 2006 Mar; 113(3-4):199-210. PubMed ID: 16352404
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
[TBL] [Abstract][Full Text] [Related]
16. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
Wei H; He J; Paulsen DB; Chowdhury SI
Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
[TBL] [Abstract][Full Text] [Related]
18. Detection of bovine herpesvirus-1 in peripheral blood mononuclear cells eight months postinfection.
Wang P; Hurley DJ; Braun LJ; Chase CC
J Vet Diagn Invest; 2001 Sep; 13(5):424-7. PubMed ID: 11580067
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
[TBL] [Abstract][Full Text] [Related]
20. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle.
Del Médico Zajac MP; Puntel M; Zamorano PI; Sadir AM; Romera SA
Res Vet Sci; 2006 Dec; 81(3):327-34. PubMed ID: 16540133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
